News + Filings Transactions Holdings
|
|
RA CAPITAL MANAGEMENT, L.P.
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
| Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
|
Legend Biotech Corp
| LEGN | SPONSORED ADR | 6,264,707 | 6,264,707 | 432,452,724,000 | 432,452,724,000 | 8.16 | |
Hist
| 06/30/2023 |
|
Vaxcyte, Inc.
| PCVX | SPONSORED ADS | 7,891,254 | 7,891,254 | 394,089,225,000 | 394,089,225,000 | 7.44 | |
Hist
| 06/30/2023 |
|
Verona Pharma plc
| VRNA | Common | 6,317,990 | 6,317,990 | 133,562,309,000 | 133,562,309,000 | 2.52 | 0.99 |
Hist
| 06/30/2023 |
|
CureVac N.V.
| CVAC | Common | 12,245,955 | 12,245,955 | 127,602,851,000 | 127,602,851,000 | 2.41 | |
Hist
| 06/30/2023 |
|
Axsome Therapeutics, Inc.
| AXSM | COM | 1,000,000 | 1,000,000 | 71,860,000,000 | 71,860,000,000 | 1.36 | |
Hist
| 06/30/2023 |
|
4D Molecular Therapeutics, Inc.
| FDMT | Common | 3,069,531 | 3,069,531 | 55,466,425,000 | 55,466,425,000 | 1.05 | 9.23 |
Hist
| 06/30/2023 |
|
Mineralys Therapeutics, Inc.
| MLYS | Common | 3,178,476 | 3,178,476 | 54,193,016,000 | 54,193,016,000 | 1.02 | 7.78 |
Hist
| 06/30/2023 |
|
Viridian Therapeutics, Inc.\DE
| VRDN | COM | 2,007,946 | 2,007,946 | 47,769,035,000 | 47,769,035,000 | 0.90 | 4.66 |
Hist
| 06/30/2023 |
|
Aclaris Therapeutics, Inc.
| ACRS | SPONSORED ADS | 4,398,453 | 4,398,453 | 45,611,958,000 | 45,611,958,000 | 0.86 | |
Hist
| 06/30/2023 |
|
Enliven Therapeutics, Inc.
| ELVN | Common | 2,122,465 | 2,122,465 | 43,319,511,000 | 43,319,511,000 | 0.82 | 5.16 |
Hist
| 06/30/2023 |
|
PLIANT THERAPEUTICS, INC.
| PLRX | Common | 1,762,000 | 1,762,000 | 31,927,440,000 | 31,927,440,000 | 0.60 | 2.98 |
Hist
| 06/30/2023 |
|
IGM Biosciences, Inc.
| IGMS | Common | 937,500 | 937,500 | 8,653,125,000 | 8,653,125,000 | 0.16 | 2.17 |
Hist
| 06/30/2023 |
|
Talaris Therapeutics, Inc.
| TALS | Common | 2,333,175 | 2,333,175 | 7,092,852,000 | 7,092,852,000 | 0.13 | 5.55 |
Hist
| 06/30/2023 |
|
|
|
|